GlassScriptPhysician profile
Kimberly A Kraus
NPI 1164405924
$7,749.14
in general payments reported to CMS, 2019-2025
48 companies · $1,256 in 2025
The $1,256 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $692 · 2021: $1,187 · 2022: $1,439 · 2023: $1,376 · 2024: $837 · 2025: $1,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157 · Education: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.71 |
| Education | $312.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,214.74 | 2019-2025 | |
| Pfizer INC. | $390.04 | 2019-2025 | |
| Millicent US INC | $388.77 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Astellas Pharma US INC | $362.04 | 2023-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $354.09 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $281.00 | 2021-2025 | |
| Avion Pharmaceuticals | $273.58 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $273.26 | 2023-2025 | Slynd, Twirla |
| Gynesonics, INC. | $224.90 | 2021 | |
| Hologic Sales and Service, LLC | $210.42 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Currax Pharmaceuticals LLC | $204.64 | 2020-2023 | Contrave |
| Sumitomo Pharma America, INC. | $196.69 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $195.54 | 2021-2024 | Twirla |
| Organon LLC | $183.73 | 2022-2025 | Nexplanon, Jada System |
| Novo Nordisk INC | $166.00 | 2022-2025 | Wegovy |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.